February 18, 2022

FTC won’t probe PBMs

After an afternoon of hearing from various stakeholders, the Federal Trade Commission decided (by a 2-2 vote) not to begin a probe of PBMs and whether and how they violate anti-trust laws.

Just three PBMs control nearly 80% of the market, and they are now affiliated with health insurers, their own pharmacies, doctor’s offices and other health-care entities to create […] both horizontal and vertical monopolies.

The good news: The commission members who voted not to probe the agency said they aren’t against it, they just needed a more comprehensive, data-centric proposal first.